Antrum Biotech

Antrum Biotech is a South African medical technology company specializing in the development of rapid diagnostic tools for infectious diseases, with a primary focus on Tuberculosis (TB). The company's flagship product, IRISA-TB, is a breakthrough diagnostic test designed to detect Extrapulmonary Tuberculosis (EPTB) using non-sputum samples such as pleural fluid. By providing results in less than two hours, IRISA-TB addresses a critical diagnostic gap where traditional sputum-based tests often fail. As a spin-off from the University of Cape Town, Antrum Biotech leverages advanced research to improve patient outcomes and reduce the global burden of TB. The company is recognized for developing the first African-manufactured rapid test for EPTB.